The Global Fund in China: Multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership.

The Global Fund in China: Multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership.

China has the world's second largest burden of multidrug-resistant tuberculosis (MDR-TB; resistance to at least isoniazid and rifampicin), with an estimated 57,000 cases (range, 48,000-67,000) among notified pulmonary TB patients in 2015. During October 1, 2006-June 30, 2014, China expanded MDR...

Full description

Bibliographic Details
Main Authors: Lixia Wang, Renzhong Li, Caihong Xu, Hui Zhang, Yunzhou Ruan, Mingting Chen, Dongmei Wang, Emilio Dirlikov, Xin Du, Jin Zhao, Yanlin Zhao, ShengFen Wang, Yuhong Liu, Liang Li, Dennis Falzon, Yanni Sun, Yu Wang, Bernhard Schwartländer, Fabio Scano
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5476250?pdf=render

Internet

http://europepmc.org/articles/PMC5476250?pdf=render

Similar Items